Skip to content

AARD AARD Return on assets

Return on assets at other companies

AbbVie logo
AbbVieABBV
2.7%-0.3pp
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
-44.8%-17.9pp
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
-48.9%-3.0pp
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
-56.6%+15.0pp
Viking Therapeutics logo
Viking TherapeuticsVKTX
-64%-88.9pp
Arvinas logo
ArvinasARVN
-26.8%-33.0pp

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%
EPS (diluted)-$0.99-39.4%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total equity$87.0M-42.3%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
CapEx--100%
Free cash flow-$16.8M-117%

Valuation

See full
Market cap$124.35M-58.6%
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×
Current ratio8.1×-17.8×

Where this comes from

Calculated from AARD’s reported figures.

Based on trailing twelve months.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's return on assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's return on assets?
AARD (AARD) reported return on assets of -54.7% in Q1 2026.
What does return on assets mean?
Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.